輸入代號或公司名稱後按 Enter
4175

杏一

-0.50 (-0.98%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
50.5021成交張數13.32本益比1.40股價淨值比5.94%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.39104.4%3.790.592.8%3.78%10.79%
2026Q10.43-58.3%3.080.181.0%1.16%8.41%
2025Q41.24-12.1%3.680.522.5%3.41%10.31%
2025Q30.7352.1%3.850.311.6%2.12%11.27%
2025Q20.683.600.291.4%1.93%10.78%
2025Q11.032.740.442.3%2.94%7.83%
2024Q41.41370.0%1.650.602.9%4.17%4.80%
2024Q30.4860.0%0.540.201.1%1.47%1.61%
2024Q2-0.18-316.6%0.36-0.08-0.4%-0.56%1.20%
2024Q1-0.06-113.4%0.62-0.02-0.1%-0.17%1.81%
2023Q40.30-34.2%1.130.130.6%0.88%3.33%
2023Q30.30-70.9%1.290.140.8%1.00%3.83%
2023Q20.08-96.1%2.020.020.1%0.12%5.91%
2023Q10.45-43.0%4.070.181.0%1.29%11.91%
2022Q40.46-21.9%4.410.181.0%1.37%13.46%
2022Q31.034.530.402.3%3.16%14.35%
2022Q22.13180.1%3.240.834.0%6.75%10.94%
2022Q10.7810.3%1.870.301.9%2.53%6.19%
2021Q40.58-34.9%1.800.231.3%1.94%6.05%
2021Q3-0.26-233.5%2.11-0.10-0.6%-0.88%7.21%
2021Q20.7673.1%2.570.291.7%2.64%9.23%
2021Q10.71-50.3%2.240.271.8%2.45%7.61%
2020Q40.90-18.5%2.960.332.1%3.18%10.72%
2020Q30.19-78.5%3.170.080.5%0.75%11.79%
2020Q20.44-54.2%3.880.171.2%1.59%14.52%
2020Q11.4341.4%4.400.523.6%4.90%15.18%
2019Q41.10-6.0%3.980.392.7%4.10%15.06%
2019Q30.9164.8%4.050.322.4%3.49%16.09%
2019Q20.9660.9%3.690.342.6%3.71%15.00%
2019Q11.0116.5%3.330.362.9%3.92%12.89%
2018Q41.1727.8%3.190.413.3%4.72%12.84%
2018Q30.55-27.4%2.930.201.7%2.30%12.33%
2018Q20.6056.2%3.140.211.9%2.45%13.46%
2018Q10.8753.5%2.920.312.8%3.49%11.69%
2017Q40.928.5%2.620.322.8%3.82%11.98%
2017Q30.768.6%2.550.262.4%3.22%11.49%
2017Q20.38-52.1%2.490.141.3%1.67%11.30%
2017Q10.57-35.5%2.910.181.8%2.36%11.71%
2016Q40.843.220.262.4%3.99%
2016Q30.700.222.2%3.60%